- Home
- GRC vs LENZ Comparison
GRC vs LENZ Comparison
Compare GRC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRC
- LENZ
- Stock Information
- Founded
- GRC 1933
- LENZ 2019
- Country
- GRC United States
- LENZ United States
- Employees
- GRC N/A
- LENZ N/A
- Industry
- GRC Fluid Controls
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- GRC Industrials
- LENZ Health Care
- Exchange
- GRC Nasdaq
- LENZ Nasdaq
- Market Cap
- GRC 1.2B
- LENZ 1.2B
- IPO Year
- GRC N/A
- LENZ 2021
- Fundamental
- Price
- GRC $46.53
- LENZ $31.84
- Analyst Decision
- GRC
- LENZ Strong Buy
- Analyst Count
- GRC 0
- LENZ 4
- Target Price
- GRC N/A
- LENZ $56.25
- AVG Volume (30 Days)
- GRC 98.7K
- LENZ 1.2M
- Earning Date
- GRC 10-24-2025
- LENZ 11-05-2025
- Dividend Yield
- GRC 1.59%
- LENZ N/A
- EPS Growth
- GRC 31.51
- LENZ N/A
- EPS
- GRC 1.91
- LENZ N/A
- Revenue
- GRC $678,522,000.00
- LENZ $5,000,000.00
- Revenue This Year
- GRC $4.94
- LENZ N/A
- Revenue Next Year
- GRC $4.47
- LENZ $285.82
- P/E Ratio
- GRC $24.35
- LENZ N/A
- Revenue Growth
- GRC 3.19
- LENZ N/A
- 52 Week Low
- GRC $30.87
- LENZ $16.54
- 52 Week High
- GRC $49.25
- LENZ $50.40
- Technical
- Relative Strength Index (RSI)
- GRC 54.81
- LENZ 33.24
- Support Level
- GRC $45.34
- LENZ $30.66
- Resistance Level
- GRC $49.21
- LENZ $42.98
- Average True Range (ATR)
- GRC 1.23
- LENZ 3.10
- MACD
- GRC 0.08
- LENZ -1.51
- Stochastic Oscillator
- GRC 54.13
- LENZ 7.69
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.